fbpx
September 16, 2020

Common Apnea Treatment Tied to Lower Dementia Risk Common Apnea Treatment Tied to Lower Dementia Risk

Obstructive sleep apnea (OSA) treatment with positive airway pressure (PAP) therapy was associated with a lower odds of incident Alzheimer’s disease and other dementia in a […]
September 15, 2020

B Cell Test Predicts Alemtuzumab Autoimmunity in MS B Cell Test Predicts Alemtuzumab Autoimmunity in MS

A common adverse effect of the multiple sclerosis (MS) treatment alemtuzumab (Lemtrada) may be predicted by pre-treatment levels of certain types of B cells, a new […]
September 15, 2020

Sense of Time Can Be Skewed by Repeated Exposure to a Fixed-duration Stimulus Sense of Time Can Be Skewed by Repeated Exposure to a Fixed-duration Stimulus

(Reuters Health) – Although we are normally very good at estimating time – say, of an eighth note or a sixteenth note – our brain’s sense […]
September 15, 2020

Sleep Loss Unleashes Anger Sleep Loss Unleashes Anger

A good night’s sleep may be important for anger management in new findings that suggest sleep loss amplifies frustration. In a series of studies, researchers found […]
September 14, 2020

‘Startling’ Decline in BP Control Among American Adults ‘Startling’ Decline in BP Control Among American Adults

After years of improvement, the number of Americans whose blood pressure (BP) is under control is declining, suggest two new analyses of data from the National […]
September 14, 2020

Bedtime Virtual Reality Intervention May Improve Teens’ Sleep Bedtime Virtual Reality Intervention May Improve Teens’ Sleep

The combination of immersive virtual reality (VR) and slow breathing techniques helps promote bedtime relaxation and improves overall sleep quality in adolescents with and those without […]
September 14, 2020

High Plasma GFAP Level Predicts Disability in Progressive MS High Plasma GFAP Level Predicts Disability in Progressive MS

A high level of glial fibrillary acidic protein (GFAP) in the blood may predict worsening disability in patients with secondary progressive multiple sclerosis (MS), according to […]
September 13, 2020

Masitinib Impresses in ‘Nonactive’ Progressive MS Masitinib Impresses in ‘Nonactive’ Progressive MS

The investigational drug, masitinib (AB Science), which has a completely new mechanism of action for multiple sclerosis (MS), has shown a positive result in slowing disability […]
September 13, 2020

Multiple Sclerosis Prodrome Holds Promise of Earlier Diagnosis Multiple Sclerosis Prodrome Holds Promise of Earlier Diagnosis

“It is time that the prodromal phase of multiple sclerosis is formally recognized.” That was the conclusion of Helen Tremlett, PhD, delivering the opening plenary session […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0